Project Details
Description
GRASP LGMD Defining Clinical Endpoints in LGMD Subtype 2E, 2D, 2F and 2C
| Status | Finished |
|---|---|
| Effective start/end date | 10/30/21 → 12/31/25 |
Funding
- VIRGINIA COMMONWEALTH UNIVERSITY
- SAREPTA THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.